Nonoperative Management of Blunt Splenic Injuries: Factors Influencing Success in Age >55 Years.
- Published in:
- American Surgeon, 2002, v. 68, n. 3, p. 227, doi. 10.1177/000313480206800303
- By:
- Publication type:
- Article
Works matching AU Schermer, Carol R.
Results: 21
1
2
Stab Wounds to the Back/Flank in Hemodynamically Stable Patients: Evaluation using Triple-Contrast Computed Tomography.
- Published in:
- American Surgeon, 1999, v. 65, n. 7, p. 683, doi. 10.1177/000313489906500715
- By:
- Publication type:
- Article
3
Erratum to: Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome.
- Published in:
- 2016
- By:
- Publication type:
- corrected article
4
Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome.
- Published in:
- 2015
- By:
- Publication type:
- journal article
5
Implications of alcohol intoxication at the time of burn and smoke inhalation injury: an epidemiologic and clinical analysis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
6
Implications of formal alcohol screening in burn patients.
- Published in:
- 2009
- By:
- Publication type:
- journal article
7
Adverse clinical outcomes associated with elevated blood alcohol levels at the time of burn injury.
- Published in:
- 2008
- By:
- Publication type:
- journal article
8
A randomized trial of Plasma-Lyte A and 0.9 % sodium chloride in acute pediatric gastroenteritis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
9
Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR).
- Published in:
- 2020
- By:
- Publication type:
- journal article
10
Pre-hospital transport times and survival for Hypotensive patients with penetrating thoracic trauma.
- Published in:
- Journal of Emergencies, Trauma & Shock, 2013, v. 6, n. 1, p. 16, doi. 10.4103/0974-2700.106320
- By:
- Publication type:
- Article
11
Comparative Safety and Efficacy of Treatments for Overactive Bladder Among Older Adults: A Network Meta-analysis.
- Published in:
- Drugs & Aging, 2020, v. 37, n. 11, p. 801, doi. 10.1007/s40266-020-00792-9
- By:
- Publication type:
- Article
12
Safety and Tolerability Results from the PILLAR Study: A Phase IV, Double-Blind, Randomized, Placebo-Controlled Study of Mirabegron in Patients ≥ 65 years with Overactive Bladder-Wet.
- Published in:
- Drugs & Aging, 2020, v. 37, n. 9, p. 665, doi. 10.1007/s40266-020-00783-w
- By:
- Publication type:
- Article
13
Comparison of Objective Screening and Self-Report for Alcohol and Drug Use in Traumatically Injured Patients.
- Published in:
- Alcoholism Treatment Quarterly, 2012, v. 30, n. 4, p. 433, doi. 10.1080/07347324.2012.718959
- By:
- Publication type:
- Article
14
A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study).
- Published in:
- International Urogynecology Journal, 2018, v. 29, n. 2, p. 273, doi. 10.1007/s00192-017-3377-5
- By:
- Publication type:
- Article
15
A prospective study of elderly initiating mirabegron versus antimuscarinics: Patient reported outcomes from the Overactive Bladder Satisfaction Scales and other instruments.
- Published in:
- Neurourology & Urodynamics, 2018, v. 37, n. 1, p. 177, doi. 10.1002/nau.23271
- By:
- Publication type:
- Article
16
Cost-minimization analysis of two fluid products for resuscitation of critically injured trauma patients.
- Published in:
- American Journal of Health-System Pharmacy, 2014, v. 71, n. 6, p. 470, doi. 10.2146/ajhp130295
- By:
- Publication type:
- Article
17
Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER).
- Published in:
- 2018
- By:
- Publication type:
- journal article
18
DJELOTVORNOST, SIGURNOST I PODNOŠLJIVOST MIRABEGRONA U BOLESNIKA U DOBI OD = 65 GODINA S MOKRIM TIPOM PREKOMJERNO AKTIVNOG MOKRAĆNOG MJEHURA: DVOSTRUKO SLIJEPO, RANDOMIZIRANO, PLACEBOM KONTROLIRANO ISPITIVANJE FAZE IV (PILLAR).
- Published in:
- Acta Medica Croatica, 2022, v. 76, n. 2/3, p. 179
- By:
- Publication type:
- Article
19
A mirabegron hatásossága, biztonságossága és tolerálhatósága ≥65 éves, nedves típusú hiperaktív hólyag szindrómában szenvedő betegeknél: IV. fázisú, kettős vak, randomizált, placebokontrollos vizsgálat (PILLAR).
- Published in:
- Magyar Nőorvosok Lapja, 2020, v. 83, n. 6, p. 357
- By:
- Publication type:
- Article
20
Antimuscarinic Discontinuation in Patients with Overactive Bladder in Nursing Homes: A Retrospective Study of Medicare Beneficiaries.
- Published in:
- Advances in Therapy, 2020, v. 37, n. 8, p. 3584, doi. 10.1007/s12325-020-01412-z
- By:
- Publication type:
- Article
21
Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE).
- Published in:
- 2019
- By:
- Publication type:
- journal article